[{"address1": "Aspen Place", "address2": "9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge", "city": "Durban", "country": "South Africa", "phone": "27 31 580 8600", "website": "https://www.aspenpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen Bradley Saad BCom, CA(SA)", "age": 59, "title": "Group CEO & Executive Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 1073341, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean M. Capazorio", "age": 56, "title": "Group CFO & Executive Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 584050, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lorraine  Hill", "age": 59, "title": "Group Chief Operations Officer & Responsible Pharmacist", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 629427, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Guy Attridge B.Com., CA(SA)", "age": 62, "title": "Group Chief Advisor", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 473508, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Reginald  Haman Grad. Dip., MBA, ND, NHD, PGDBA", "age": 48, "title": "Group Chief Corporate Services Officer & Executive Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 440588, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Zizipho  Mmango", "age": 38, "title": "Group Chief Strategic Development Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 440532, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sibongakonke  Nkosi", "title": "Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Trevor Julian Ziman", "age": 51, "title": "Regional Chief Executive Officer of Asia Pacific", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Samer  Kassem", "age": 48, "title": "Chief Executive Officer of Aspen Global Incorporated", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Raeesa  Khan", "title": "Group Company Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.aspenpharma.com/default.aspx?pid=5&stepid=1&oid=5", "maxAge": 86400, "priceHint": 2, "previousClose": 12.0, "open": 12.0, "dayLow": 12.0, "dayHigh": 12.0, "regularMarketPreviousClose": 12.0, "regularMarketOpen": 12.0, "regularMarketDayLow": 12.0, "regularMarketDayHigh": 12.0, "dividendRate": 0.2, "dividendYield": 0.0164, "exDividendDate": 1726617600, "payoutRatio": 0.3121, "beta": 0.692, "trailingPE": 20.07377, "volume": 100, "regularMarketVolume": 100, "averageVolume": 1, "bid": 10.66, "ask": 12.03, "bidSize": 40000, "askSize": 36900, "marketCap": 5439694336, "fiftyTwoWeekLow": 9.2, "fiftyTwoWeekHigh": 12.245, "priceToSalesTrailing12Months": 0.12167705, "fiftyDayAverage": 12.245, "twoHundredDayAverage": 10.1778, "trailingAnnualDividendRate": 3.59, "trailingAnnualDividendYield": 0.29916665, "currency": "USD", "enterpriseValue": 29556004864, "profitMargins": 0.09851, "floatShares": 278366321, "sharesOutstanding": 444238016, "heldPercentInsiders": 0.19328, "heldPercentInstitutions": 0.66382, "impliedSharesOutstanding": 482247008, "bookValue": 191.085, "priceToBook": 0.06408143, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": -0.182, "netIncomeToCommon": 4403999744, "trailingEps": 0.61, "enterpriseToRevenue": 0.661, "enterpriseToEbitda": 3.295, "52WeekChange": 0.33097827, "SandP52WeekChange": 0.24014747, "lastDividendValue": 3.59, "lastDividendDate": 1726617600, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "APNHF", "underlyingSymbol": "APNHF", "shortName": "ASPEN PHARMACARE HLDGS", "longName": "Aspen Pharmacare Holdings Limited", "firstTradeDateEpochUtc": 1272547800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "da133607-6746-3fd9-b57b-ce0926a0085e", "messageBoardId": "finmb_4481307", "gmtOffSetMilliseconds": -14400000, "currentPrice": 12.245, "recommendationKey": "none", "totalCash": 12337000448, "totalCashPerShare": 27.78, "ebitda": 8970999808, "totalDebt": 36454998016, "quickRatio": 1.07, "currentRatio": 1.808, "totalRevenue": 44706000896, "debtToEquity": 42.958, "revenuePerShare": 100.644, "returnOnAssets": 0.03199, "returnOnEquity": 0.05148, "freeCashflow": -10625000, "operatingCashflow": 6224999936, "earningsGrowth": -0.181, "revenueGrowth": 0.093, "grossMargins": 0.43515, "ebitdaMargins": 0.20066999, "operatingMargins": 0.14844, "financialCurrency": "ZAR", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]